Lung Cancer Clinical Trial

Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC

Summary

This will be the first prospective study where patients will be selected on the basis of two measures of the epidermal growth factor receptor (EGFR) pathway. The study will assess prospectively the efficacy of erlotinib as a single agent or intercalated with chemotherapy in highly selected patients with EGFR overexpression and/or EGFR amplification.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age >= 18
Histologically or cytologically documented non-small cell lung cancer (NSCLC)
Eastern Cooperative Oncology Group (ECOG)performance status (PS)0, 1, 2
Radiologically measurable or evaluable disease No prior chemotherapy
1 or 2 epithelial growth factor receptor (EGFR) pathway markers positive at screening
Tumor tissue block or fine needle aspirate

Exclusion Criteria:

Any concurrent anticancer therapy or radiation
Other active malignancy
Uncontrolled brain metastases
GI abnormalities
Severe abnormalities of the cornea
Significant cardiac disease
Active infection

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

143

Study ID:

NCT00294762

Recruitment Status:

Completed

Sponsor:

OSI Pharmaceuticals

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 42 Locations for this study

See Locations Near You

Central Hematology Oncology Medical Group Inc.
Alhambra California, 91801, United States
Comprehensive Blood and Cancer Center(Part of TORI network)
Bakersfield California, 93309, United States
Bay Area Cancer Research Group
Concord California, 94520, United States
Virginia K. Crosson Cancer Center
Fullerton California, 92835, United States
Pacific Shores Medical Group
Long Beach California, 90813, United States
UCLA Medical Center
Los Angeles California, 90095, United States
North Valley Hematology/Oncology Medical GroupThe Thomas and Dorothy Leavey Cancer Center
Northridge California, 91325, United States
Ventura County Hematology-Oncology Specialists
Oxnard California, 93030, United States
Wilshire Oncology Medical GroupThe Robert and Beverly Lewis Family Cancer Care Center
Pomona California, 91767, United States
Cancer Care Associates Medical Group, Inc.
Redondo Beach California, 90277, United States
Sansum Santa Barbara Medical Foundation Clinic
Santa Barbara California, 93105, United States
Santa Barbara Hematology Oncology Medical Group, Inc.
Santa Barbara California, 93105, United States
University of Colorado Cancer Center
Aurora Colorado, 80045, United States
Rocky Mountain Cancer CenterResearch Department
Denver Colorado, 80218, United States
Eastern Connecticut Hematology and Oncology Associates
Norwich Connecticut, 06360, United States
MD Anderson Cancer Ctr - Orlando
Orlando Florida, 32806, United States
Gulfcoast Oncology Associates
Tampa Florida, 33614, United States
Suburban Hematology-Oncology Associates
Lawrenceville Georgia, 30045, United States
Central Georgia Cancer Care, P.C.
Macon Georgia, 31201, United States
Rush-Presbyterian-St.Luke's Med Ctr
Chicago Illinois, 60612, United States
University of Chicago Medical Center
Chicago Illinois, 60637, United States
Norton Healthcare, Inc.
Louisville Kentucky, 40202, United States
Karmanos Cancer Institute
Detroit Michigan, 48201, United States
Univ. of Minnesota Cancer Center
Minneapolis Minnesota, 55455, United States
Hematology Oncology Centers of Northern Rockies Research
Billings Montana, 59101, United States
Alegent Healthcare
Omaha Nebraska, 68124, United States
Comprehensive Cancer Centers of Nevada
Henderson Nevada, 89052, United States
Hematology-Oncology Associates, SJ, PA - Virtua Health
Mount Holly New Jersey, 08060, United States
Providence Portland Medical Center
Portland Oregon, 97213, United States
Fox Chase Cancer Center
Philadelphia Pennsylvania, 19111, United States
Pottsville Cancer Clinic
Pottsville Pennsylvania, 17901, United States
Boston Baskin Cancer Groupd/b/a U. of Tennessee Cancer Inst.
Memphis Tennessee, 38104, United States
The West Cancer Clinic
Memphis Tennessee, 38120, United States
ACORN
Memphis Tennessee, 38138, United States
University of Texas M.D. Anderson Cancer Center
Houston Texas, 77030, United States
Fletcher Allen Health Care
Burlington Vermont, 05401, United States
Cancer Specialists of Tidewater, Ltd.
Chesapeake Virginia, 23320, United States
Fred Hutchinson Cancer Research Center
Seattle Washington, 98109, United States
Birmingham Heartlands Hospital
Birmingham , B9 5S, United Kingdom
CR UK
Cambridge , CB2 2, United Kingdom
Peterborough District Hospital
Cambridge , PE3 6, United Kingdom
Beatson Oncology Centre
Glasgow , G11 6, United Kingdom
Mount Vernon Hospital
Middlesex , HA6 2, United Kingdom

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

143

Study ID:

NCT00294762

Recruitment Status:

Completed

Sponsor:


OSI Pharmaceuticals

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider